Ra Pharmaceuticals IPO Off to a Strong Start
Ra Pharmaceuticals had a very strong entrance to the market on Wednesday, with shares going out at the top of the expected price range.
Health and Healthcare
All Health and Healthcare Articles
Newest first · Page 190
Boston Scientific Remains Flat After Meeting Earnings
Boston Scientific reported its third-quarter financial results before the markets opened on Wednesday.
Biogen Rises on Solid Earnings Beat
Biogen reported better-than-expected third-quarter financial results before the markets opened on Wednesday,
Short Sellers Grow More Selective on Major Pharma Stocks
The October 14 short interest data have been compared with the previous figures, and for the selected pharmaceutical stocks short interest was mixed.
Short Sellers Can’t Make Up Their Minds on Major Biotechs
The October 14 short interest data have been compared with the previous report, and short interest moves in these selected biotech stocks were mixed.
Is This the Beginning of the End of a Dipexium Implosion?
Dipexium Pharmaceuticals Inc. (NASDAQ: DPRX) is watching its shares in free fall on Tuesday after the company announced data from its late-stage trial. The question on everyone’s mind is whether or not this is…
What to Expect From Merck Earnings
Merck is scheduled to release its third-quarter earnings report after before the markets open on Tuesday.
What to Look for When Eli Lilly Reports Earnings
Eli Lilly plans to release its most recent earnings report before the markets open on Tuesday, and analysts expect top and bottom line growth.
Why Negative Analyst Views May Matter So Much on Ariad
Ariad Pharmaceuticals shares were down handily on Monday after JPMorgan downgraded the stock. Also Senator Sanders recently asked about the pricing of its blood cancer drug Iclusig.
aTyr Receives FDA Fast Track Designation
aTyr Pharma watched its shares climb early on Monday after the company announced that its product candidate Resolaris was granted Fast Track designation by the FDA.
Inovio Pharma Tanks on FDA Clinical Hold
Shares of Inovio Pharmaceuticals slid in Monday’s session on news that the FDA placed a clinical hold on a proposed Inovio Phase 3 clinical program.
Are Alkermes Analysts Chasing This Story Too Hard, or Is It Just a Start?
Is it possible that analysts are now behind the curve on Alkermes? Or worse, are they chasing their expectations too high?
Top Health Care Earnings Coming Next Week
Earnings season is now in full swing, and we have put together a preview of Bristol-Myers, AbbVie and some of the other top players in the health care sector.
2 Diet Drinks a Day Could Double Diabetes Risk
The European Society of Endocrinology has just published a study about diabetes risks that soda manufacturers will not like.
Why Despite Alkermes Success, Suicidal Ideation Still Eludes Big Pharma
Alkermes' positive Phase 3 results for its novel antidepressant is serving as a rising tide — a storm surge even — for many biotech companies in the depression space.